Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

World Sleep 2022 | Physiological-based model to predict treatment outcomes in OSA

Danny Eckert, PhD, Adelaide Institute for Sleep Health, Flinders University, Adelaide, Australia, discusses a recently developed physiological-based model that uses standard polysomnography and clinical data to predict oral appliance treatment outcomes in obstructive sleep apnea (OSA). This model uses machine learning to negate the requirement for comprehensive laboratory testing to measure disease endotypes, which is generally impractical for clinical purposes. The application has demonstrated an 80% accuracy rate in predicting patient response to oral appliance therapy, compared to about 50% when using apnea hypoxia index (AHI) based phenotyping. This interview was recorded at the World Sleep Congress 2022 in Rome, Italy.

Disclosures

Dr. Eckert is funded by a National Health and Medical Research Council (NHMRC) of Australia Leadership Fellowship. He has also received research grants from Takeda, Bayer, Invicta Medical, Apnimed and a Cooperative Research Centre Grant (collaboration between the Australian Government, Academia and Industry- Industry partner Oventus Medical), and served as a consultant and/or advisory board member for Takeda, Bayer, Invicta Medical, Apnimed and Eisai.